Jingjing Zhao

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Yi Xiao, Ding Ma, Shen Zhao et al. · Clinical Cancer Research · 2019 · 366 citations · Full text

Medicine, Cancer Biology, Oncology +17

Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR‐α/sirtuin 1/PGC‐1α pathway

Guangzhong Liu, Tingting Hou, Yue Yuan et al. · British Journal of Pharmacology · 2016 · 91 citations · Full text

Medicine, Cardiology, Pharmacology +15

The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors

Changwen Deng, Jingjing Zhao, Shixin Zhou et al. · Molecular Therapy · 2019 · 66 citations · Full text

Medicine, Immunology, Oncology +16

Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model

Ruidi Teng, Jingjing Zhao, Yiding Zhao et al. · Journal of Immunotherapy · 2018 · 52 citations · Full text

Life Sciences, Immunology, Oncology +17

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma

Yue Huang, Ying‐Qin Zhu, Jieying Yang et al. · Cell Death and Disease · 2022 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17